GATC Biotech conducts research to detect cancer in women

15-Jan-2013 - Germany

GATC Biotech has started research on early detection of breast and ovarian cancer with the goal of developing a test to identify tumor markers present in blood and link these markers to the presence of cancer.

As a partner of the research project EpiFemCare, GATC Biotech will manage sample processing, i.e. the DNA isolation from serum and the reduced representation bisulfite sequencing from serum derived DNA. This method analyses DNA methylation in normal and tumor DNA. 6 institutions from 5 European countries combining the best clinical, scientific and industrial expertise have joined forces to add a new dimension to the treatment of cancer in women. The € 5.8 Mio project from the European Commission will develop and test new methods for screening, diagnosing and personalising treatment of breast and ovarian cancer.

Other news from the department science

Most read news

More news from our other portals

Is artificial intelligence revolutionizing the life sciences?